ARTICLE | Clinical News
Trabectedin regulatory update
February 16, 2009 8:00 AM UTC
Swissmedic approved Yondelis trabectedin from PharmaMar to treat soft tissue sarcoma (STS). PharmaMar already markets the cytotoxic alkaloid that binds the minor groove of DNA in the EU for STS, and ...